Oxurion Collection (3 videos)

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Phase 1 Results for THR-687 in DME

Channels: Retina

Arshad Khanani, MD, explains integrin antagonism as a model for therapeutic treatment, and summarizes the structure and results of a phase 1 dose-escalation study that evaluated the safety of THR-687 in patients with DME. Efficacy results from the study are also reviewed.

Oxurion

Visit Us Online